Cargando…

Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome

Alexithymia is usually described by three main dimensions difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and externally oriented thinking (EOT). The most commonly used questionnaire investigating alexithymia, the Toronto Alexithymia Scale (TAS-20), supports this three-f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fournier, Alicia, Mondillon, Laurie, Luminet, Olivier, Canini, Fréderic, Mathieu, Nicolas, Gauchez, Anne Sophie, Dantzer, Cécile, Bonaz, Bruno, Pellissier, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142209/
https://www.ncbi.nlm.nih.gov/pubmed/32300314
http://dx.doi.org/10.3389/fpsyt.2020.00229
_version_ 1783519330366914560
author Fournier, Alicia
Mondillon, Laurie
Luminet, Olivier
Canini, Fréderic
Mathieu, Nicolas
Gauchez, Anne Sophie
Dantzer, Cécile
Bonaz, Bruno
Pellissier, Sonia
author_facet Fournier, Alicia
Mondillon, Laurie
Luminet, Olivier
Canini, Fréderic
Mathieu, Nicolas
Gauchez, Anne Sophie
Dantzer, Cécile
Bonaz, Bruno
Pellissier, Sonia
author_sort Fournier, Alicia
collection PubMed
description Alexithymia is usually described by three main dimensions difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and externally oriented thinking (EOT). The most commonly used questionnaire investigating alexithymia, the Toronto Alexithymia Scale (TAS-20), supports this three-factor structure. One important assumption is that alexithymia severity is associated to vulnerability to somatic diseases, among them gastrointestinal disorders. However, the association between alexithymia and gastrointestinal disorders is not systematic, thus questioning the role of alexithymia as a vulnerability factor for those illnesses. A recent factor analysis suggested another four-factor structure for the TAS-20: difficulties in awareness of feelings (DAF), difficulties in interoceptive abilities (DIA), externally oriented thinking (EOT), and poor affective sharing (PAS). We assume that DIA and DAF might be more relevant to investigate the association between alexithymia and gastrointestinal disorders. The rationale is that DIA and DAF reflect impairments in emotion regulation that could contribute to an inappropriate autonomic and HPA axis homeostasis in irritable bowel syndrome (IBS), ulcerative colitis (UC), or Crohn’s disease (CD). The aim of this study was to investigate whether DIA and DAF are associated with the presence of IBS, UC or CD, while checking for anxiety, depression, parasympathetic (vagus nerve) activity and cortisol levels. We recruited control participants (n=26), and patients in remission who were diagnosed with IBS (n=24), UC (n=18), or CD (n=21). Participants completed questionnaires to assess anxiety, depression, and alexithymia. A blood sample and an electrocardiogram were used to measure the level of cortisol and parasympathetic activity, respectively. Logistic regressions with the four-factor structure of the TAS-20 revealed that DIA was a significant predictor of IBS (W(1)=6.27, p=.01). Conversely, DIA and DAF were not significant predictors in CD and UC patients. However, low cortisol level was a significant predictor of UC (W(1)=4.67, p=.035). Additional logistic regressions based on the original 3-factor structure of TAS-20 (DIF, DDF, and EOT) showed that only DDF was a significant predictor of CD [W(1)=6.16, p < .001]. The present study suggests that DIA is an important dimension for assessing potential risk for gastrointestinal diseases, in particular for IBS.
format Online
Article
Text
id pubmed-7142209
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71422092020-04-16 Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Fournier, Alicia Mondillon, Laurie Luminet, Olivier Canini, Fréderic Mathieu, Nicolas Gauchez, Anne Sophie Dantzer, Cécile Bonaz, Bruno Pellissier, Sonia Front Psychiatry Psychiatry Alexithymia is usually described by three main dimensions difficulty identifying feelings (DIF), difficulty describing feelings (DDF), and externally oriented thinking (EOT). The most commonly used questionnaire investigating alexithymia, the Toronto Alexithymia Scale (TAS-20), supports this three-factor structure. One important assumption is that alexithymia severity is associated to vulnerability to somatic diseases, among them gastrointestinal disorders. However, the association between alexithymia and gastrointestinal disorders is not systematic, thus questioning the role of alexithymia as a vulnerability factor for those illnesses. A recent factor analysis suggested another four-factor structure for the TAS-20: difficulties in awareness of feelings (DAF), difficulties in interoceptive abilities (DIA), externally oriented thinking (EOT), and poor affective sharing (PAS). We assume that DIA and DAF might be more relevant to investigate the association between alexithymia and gastrointestinal disorders. The rationale is that DIA and DAF reflect impairments in emotion regulation that could contribute to an inappropriate autonomic and HPA axis homeostasis in irritable bowel syndrome (IBS), ulcerative colitis (UC), or Crohn’s disease (CD). The aim of this study was to investigate whether DIA and DAF are associated with the presence of IBS, UC or CD, while checking for anxiety, depression, parasympathetic (vagus nerve) activity and cortisol levels. We recruited control participants (n=26), and patients in remission who were diagnosed with IBS (n=24), UC (n=18), or CD (n=21). Participants completed questionnaires to assess anxiety, depression, and alexithymia. A blood sample and an electrocardiogram were used to measure the level of cortisol and parasympathetic activity, respectively. Logistic regressions with the four-factor structure of the TAS-20 revealed that DIA was a significant predictor of IBS (W(1)=6.27, p=.01). Conversely, DIA and DAF were not significant predictors in CD and UC patients. However, low cortisol level was a significant predictor of UC (W(1)=4.67, p=.035). Additional logistic regressions based on the original 3-factor structure of TAS-20 (DIF, DDF, and EOT) showed that only DDF was a significant predictor of CD [W(1)=6.16, p < .001]. The present study suggests that DIA is an important dimension for assessing potential risk for gastrointestinal diseases, in particular for IBS. Frontiers Media S.A. 2020-04-02 /pmc/articles/PMC7142209/ /pubmed/32300314 http://dx.doi.org/10.3389/fpsyt.2020.00229 Text en Copyright © 2020 Fournier, Mondillon, Luminet, Canini, Mathieu, Gauchez, Dantzer, Bonaz and Pellissier http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Fournier, Alicia
Mondillon, Laurie
Luminet, Olivier
Canini, Fréderic
Mathieu, Nicolas
Gauchez, Anne Sophie
Dantzer, Cécile
Bonaz, Bruno
Pellissier, Sonia
Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
title Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
title_full Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
title_fullStr Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
title_full_unstemmed Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
title_short Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
title_sort interoceptive abilities in inflammatory bowel diseases and irritable bowel syndrome
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142209/
https://www.ncbi.nlm.nih.gov/pubmed/32300314
http://dx.doi.org/10.3389/fpsyt.2020.00229
work_keys_str_mv AT fournieralicia interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT mondillonlaurie interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT luminetolivier interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT caninifrederic interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT mathieunicolas interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT gauchezannesophie interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT dantzercecile interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT bonazbruno interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome
AT pellissiersonia interoceptiveabilitiesininflammatoryboweldiseasesandirritablebowelsyndrome